SK Biotek Ireland is advancing its manufacturing capabilities with a new API facility in Dublin, backed by an investment of up to €35 million. This project is a key element of their broader strategic initiative to expand capacity within Europe and enhance production efficiency.
🔷Investment & Scope: Up to €35 million is being allocated for the development of a new, purpose-built API manufacturing facility.
🔷Facility Design & Technology: The plant is designed from the ground up for API production, incorporating advanced single-use technologies.
🔷Integrated digital manufacturing systems and automation tools are part of the design, aimed at optimizing process control and quality assurance.
🔷Analytical Services Expansion: A standalone analytical services unit is being developed at the adjacent Swords campus. This unit is focused on enhancing testing, validation, and overall quality control, thereby reducing turn around times.
🔷Operational Impact & Future Plans: Although specific facility size and workforce numbers have not been disclosed, the capital commitment reflects a significant upgrade in production capabilities.
The expansion is expected to integrate seamlessly into SK Biotek’s existing operations, with further capacity enhancements planned as market demands evolve.
Explore our library of expert insights, tools, and resources to enhance your facility's performance and efficiency.
PlantQuest's innovative solution reduced alarm response times by up to 73% and eliminated unnecessary evacuations at a major pharmaceutical facility in Leinster, Ireland. By integrating fire system and EHS asset data into a Google Maps-like platform, the solution enhanced emergency response, minimized operational disruptions, and significantly improved financial performance.
Lorem ipsum aliquam vel justo fringillas enigma.
